ArticleApplied and environmental microbiology2019
Effect of Cessation of Ceftiofur and Substitution with Lincomycin-Spectinomycin on Extended-Spectrum-β-Lactamase/AmpC Genes and Multidrug Resistance in Escherichia coli from a Canadian Broiler Production Pyramid.
Article in Applied and environmental microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.
- Comparison of different approaches to antibiotic restriction in food-producing animals: stratified results from a systematic review and meta-analysis.BMJ global health · 2019Pooled it
- Environmental Persistence and Genotypic and Phenotypic Characterization ofPathogens (Basel, Switzerland) · 2026Article
- Co-Occurrence and Molecular Characterization of ESBL-Producing and Colistin-ResistantFoods (Basel, Switzerland) · 2025Article
- Article
- Antimicrobial Susceptibility Profiles ofAntibiotics (Basel, Switzerland) · 2025Article
- Article
- Therapeutic effects of lincomycin and level of drug degradation in broiler tissues after treatment.Veterinary world · 2024Article
- Tracing the Evolutionary Pathways of Serogroup O78 Avian PathogenicAntibiotics (Basel, Switzerland) · 2023Article
- Characterization of Proteus mirabilis and associated plasmids isolated from anaerobic dairy cattle manure digesters.PloS one · 2023Article
- Antimicrobial resistance interventions in the animal sector: scoping review.Frontiers in antibiotics · 2023Review
- Modelling the impact of antimicrobial use and external introductions on commensal E. coli colistin resistance in small-scale chicken farms of the Mekong delta of Vietnam.Transboundary and emerging diseases · 2022Article
- Effect of Antibiotics on the Colonization of Live AttenuatedFrontiers in veterinary science · 2021Article
- High-resolution characterisation of ESBL/pAmpC-producing Escherichia coli isolated from the broiler production pyramid.Scientific reports · 2020Article
- Quantitative Analysis of Spectinomycin and Lincomycin in Poultry Eggs by Accelerated Solvent Extraction Coupled with Gas Chromatography Tandem Mass Spectrometry.Foods (Basel, Switzerland) · 2020Article
- Prevalence, Risk Factors, and Characterization of Multidrug Resistant and ESBL/AmpC ProducingAnimals : an open access journal from MDPI · 2020Article
- Resistance to extended-spectrum cephalosporins in Escherichia coli and other Enterobacterales from Canadian turkeys.PloS one · 2020Article
- Dissemination of Multidrug-Resistant CommensalFrontiers in microbiology · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ceftiofur, a third-generation cephalosporin antimicrobial, was used in Canadian hatcheries for many years to prevent early mortality in chicks, leading to a high prevalence of cephalosporin resistance in
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.